IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hisert, K. B.
Right arrow Articles by McKinney, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hisert, K. B.
Right arrow Articles by McKinney, J. D.
Infection and Immunity, September 2004, p. 5315-5321, Vol. 72, No. 9
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.9.5315-5321.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Identification of Mycobacterium tuberculosis Counterimmune (cim) Mutants in Immunodeficient Mice by Differential Screening

Katherine B. Hisert,1 Meghan A. Kirksey,1 James E. Gomez,1 Alexandra O. Sousa,1 Jeffery S. Cox,2 William R. Jacobs Jr.,3 Carl F. Nathan,4 and John D. McKinney1*

Laboratory of Infection Biology, The Rockefeller University,1 Weill Medical College of Cornell University, New York, New York,4 Department of Microbiology and Immunology, University of California, San Francisco, California,2 Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, New York3

Received 2 February 2004/ Returned for modification 30 March 2004/ Accepted 1 June 2004

Tuberculosis (TB) is characterized by lifetime persistence of Mycobacterium tuberculosis. Despite the induction of a vigorous host immune response that curtails disease progression in the majority of cases, the organism is not eliminated. Subsequent immunosuppression can lead to reactivation after a prolonged period of clinical latency. Thus, while it is clear that protective immune mechanisms are engaged during M. tuberculosis infection, it also appears that the pathogen has evolved effective countermechanisms. Genetic studies with animal infection models and with patients have revealed a key role for the cytokine gamma interferon (IFN-{gamma}) in resistance to TB. IFN-{gamma} activates a large number of antimicrobial pathways. Three of these IFN-{gamma}-dependent mechanisms have been implicated in defense against M. tuberculosis: inducible nitric oxide synthase (iNOS), phagosome oxidase (phox), and the phagosome-associated GTPase LRG-47. In order to identify bacterial genes that provide protection against specific host immune pathways, we have developed the strategy of differential signature-tagged transposon mutagenesis. Using this approach we have identified three M. tuberculosis genes that are essential for progressive M. tuberculosis growth and rapid lethality in iNOS-deficient mice but not in IFN-{gamma}-deficient mice. We propose that these genes are involved in pathways that allow M. tuberculosis to counter IFN-{gamma}-dependent immune mechanisms other than iNOS.


* Corresponding author. Mailing address: Laboratory of Infection Biology, The Rockefeller University, 1230 York Ave., New York, NY 10021. Phone: (212) 327-7081. Fax: (212) 327-7083. E-mail: mckinney{at}rockefeller.edu.

Editor: S. H. E. Kaufmann


Infection and Immunity, September 2004, p. 5315-5321, Vol. 72, No. 9
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.9.5315-5321.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2004 by the American Society for Microbiology. All rights reserved.